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GABAB receptors regulate the intracellular Ca
2+ concentration ([Ca2+]i) in a number of cells (e.g., retina, airway epithelium
and smooth muscle), but whether they are expressed in vascular endothelial cells and similarly regulate the [Ca2+]i is not
known. The purpose of this study was to investigate the expression of GABAB receptors, a subclass of receptors to the inhibitory
neurotransmitter 𝛾-aminobutyric acid (GABA), in cultured human aortic endothelial cells (HAECs), and to explore if altering
receptor activation modified [Ca2+]i and endothelial nitric oxide synthase (eNOS) translocation. Real-time PCR, western blots and
immunofluorescence were used to determine the expression of GABAB1 and GABAB2 in cultured HAECs. The effects of GABAB
receptors on [Ca2+]i in cultured HAECs were demonstrated using fluo-3.The influence of GABAB receptors on eNOS translocation
was assessed by immunocytochemistry. BothGABAB1 andGABAB2 mRNA and protein were expressed in culturedHAECs, and the
GABAB1 and GABAB2 proteins were colocated in the cell membrane and cytoplasm. One hundred 𝜇M baclofen caused a transient
increase of [Ca2+]i and eNOS translocation in cultured HAECs, and the effects were attenuated by pretreatment with the selective
GABAB receptor antagonists CGP46381 and CGP55845. GABAB receptors are expressed in HAECs and regulate the [Ca
2+]i and
eNOS translocation. Cultures of HAECs may be a useful in vitromodel for the study of GABAB receptors and vascular biology.
1. Introduction
GABAB receptors, a distinct subclass of receptors to the
inhibitory neurotransmitter 𝛾-aminobutyric acid (GABA),
comprised of two principal heterodimeric subunits GABAB1
andGABAB2 [1–3], aremembers of themetabotropic receptor
family that via Gi/o proteins interact with neuronal inwardly
rectifying potassium and voltage-gated calcium channels
and when activated mediate slow synaptic inhibition [4].
GABAB receptors are mainly located within the central
nervous system and retina [5, 6] and modulate intracellular
calcium concentration ([Ca2+]i) in selected neural cells (e.g.,
chromaffin cells [7], dopaminergic neurons [8], and cortical
neurons [9]). GABAB receptors have also been detected in
peripheral tissues, including human and guinea pig airway
epithelium [10], human fallopian tube [11], and human airway
smooth muscle [12], and shown to participate in the [Ca2+]i
modulation [13].
Vascular endothelial cells are principal cells of blood
vessels and play crucial roles within the vasculature. Intra-
cellular Ca2+ contributes to vascular endothelium physi-
ology, functions, and disorders such as proliferation [14],
apoptosis [15], permeability [16], endothelial nitric oxide
synthase (eNOS) activation [17], injury [18], and healing [19].
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Other neural-transmitter receptor types that are generally
thought of as having primarily central neural system loca-
tions and functions have been shown to be present within
the peripheral vascular endothelium cells and modify the
intracellular Ca2+. For example, the muscarinic receptor
subtypes 1 and 3 were detected in human vascular endothelial
cells [20]. Acetylcholine increases the [Ca2+]i in primary
cultured rabbit aortic endothelial cells, and this can be
blocked by the selective muscarinic receptor antagonist
atropine [21]. 𝛽-Adrenoceptors are present in the endothe-
lium of the rabbit coronary artery [22]. Epinephrine induces
endothelial Ca2+ influx and thus increases the [Ca2+]i in
primary cultured bovine aortic endothelial cells and this
can be inhibited by a 𝛽2-adrenoceptor antagonist ICI-118551
[23]. 5-Hydroxytryptamine (5-HT)1D, 5-HT2B, and 5-HT4
receptors are expressed in human umbilical vein endothelial
cells [24, 25]. 5-HT stimulates Ca2+ uptake and this can be
inhibited by 5-HT receptor antagonists [26].
As the major source of nitric oxide (NO) in vascu-
lar endothelial cells [27], endothelial nitric oxide synthase
(eNOS) plays a crucial role within the cardiovascular sys-
tem. The subcellular location of eNOS contributes to the
enzyme functions [27]. In resting endothelial cells, eNOS
is mainly located at the cell membrane and cytoplasm, and
when stimulated by agonists, it translocates to structures
within the cell cytosol close to the nucleus [27, 28]. eNOS
translocation can be induced by a variety of agents, some of
which stimulate the [Ca2+]i increase in endothelial cells. For
example, acetylcholine [21, 29], endothelin-1 [30, 31], platelet-
activating factor [29, 32], bradykinin [28], estrogen [33], and
epicatechin [34] increase the [Ca2+]i in endothelial cells and
induce eNOS translocation. Thus, GABAB receptors regulate
the [Ca2+]i in some neural and nonneural cells [7–9, 13];
whether they are expressed in vascular endothelial cells and
regulate the [Ca2+]i and eNOS translocation is not clear.
Based on indirect evidence, we hypothesized that GABAB
receptors would be expressed in human aortic endothelial
cells (HAECs). The purpose of this study was to investigate
whether GABAB receptors are expressed in cultured HAECs
and regulate the [Ca2+]i and eNOS translocation. If these
receptors are present, HAECs could be a useful model for
studying a direct role of GABA in vascular regulation.
2. Methods
2.1. Cell Culture. Primary HAECs obtained from the Amer-
ican Type Cell Collection (VA, USA) were cultured in
endothelial cell medium (ECM) containing 5% FBS and 1%
endothelial cell growth supplement (ScienCell, USA) at 37∘C
with humidified air and 5% CO
2
. HAECs of no more than
passage 4 were used.The study was carried out in accordance
with “The Code of Ethics of the World Medical Associa-
tion (Declaration of Helsinki)” for experiments involving
humans.
2.2. Real-Time PCR. RNA isolation and reverse transcription
were performed as previously described [35]. RNA concen-
tration and purity were determined at an optical density ratio
of 260 : 280 using a spectrophotometer. Primers for human
GABAB1 and GABAB2 were designed to span a region that
includes an intron in the genomic sequence for these genes
and ordered from Shanghai Biosune Biotechnology Com-
pany (Shanghai, China). The primers for GABAB1 were for-
ward 5󸀠-GCCGCTGTGTCCGAATCTGCT-3󸀠 and reverse
5󸀠-CTGCGCGCCGTTCTGAGTGT-3󸀠, and for GABAB2
they were forward 5󸀠-TGGAGGCGTCTGTCCATCCGT-
3󸀠 and reverse 5󸀠-GTCTTGCGTCAGCGTGCCCA-3󸀠. SYBR
Green real-time PCR and quantitative assays were performed
by use of a Real-time PCR Detection System, LightCycler
(Roche Applied Science, IN, USA). Denaturation was per-
formed for 10 s at 95∘C, annealing for 10 s at 60∘C, and
extension for 10 s at 72∘C. cDNA from the human retinal
tissue was used as the positive control and the samples
without cDNAwere used as the negative control. 𝛽-Actin was
used as the housekeeping gene. Correct product size (228 bp
for GABAB1 and 220 bp for GABAB2) was confirmed by DNA
agarose gel, and sequence comparison with target genes was
conducted (by Biosune Biotechnology Company, Shanghai).
Samples were analyzed in triplicate.
2.3. Immunocytochemistry. Immunocytochemistry was per-
formed as previously described [36]. Briefly, cells were fixed
with 4%paraformaldehyde, blockedwith 10%normal donkey
serum, and incubated with mouse anti-human GABAB1
antibody (1 : 500; Abcam, USA), goat anti-human GABAB2
antibody (1 : 100; Santa Cruz, CA, USA), or rabbit anti-
human eNOS antibody (1 : 100; Sigma, USA) overnight at
4∘C. Subsequently, the cells were incubated with donkey anti-
mouse secondary antibody (Alexa 568 conjugated; 1 : 1000;
Invitrogen, CA, USA), donkey anti-goat secondary antibody
(Alexa 488 conjugated; 1 : 1000; Invitrogen, CA, USA), and
donkey anti-rabbit secondary antibody (Alexa 488 conju-
gated; 1 : 1000; Invitrogen, CA, USA) for 1 h at 37∘C. A drop
of Prolong Gold anti-fade reagent with DAPI (Invitrogen,
CA, USA) was added before cell images were acquired by use
of a LSM 710 laser confocal microscope (EC Plan-Neofluar
40×/1.30 Oil objective, N.A. 0.55) equipped with ZEN 2009
Light Edition software (Zeiss, Germany).
2.4. Western Blots. Western blots were performed as pre-
viously described [35, 36]. HAECs and human retinal tis-
sue (positive control) protein samples were separated by
7.5% SDS-PAGE and transferred to polyvinylidene difluoride
(PVDF) membranes. After 1 h defatted milk block, the mem-
branewas incubatedwith the anti-GABAB1 antibody (Abcam,
1 : 1000) and anti-GABAB2 antibody (Santa Cruz; 1 : 200) and
then with horseradish peroxidase- (HRP-) conjugated sec-
ondary antibody (1 : 5000). The bands were visualized by use
of Immobilon Western Chemiluminescent HRP Substrate
(Millipore, MA, USA).
2.5. Measuring [Ca2+]i. [Ca2+]i was measured as previously
described [37] with minor modification. HAECs were cul-
tured on a glass-covered disc with a concentration of 5
× 105 cells/mL. Two days later, the cells were incubated
with 5 𝜇M fluo-3 AM for 20min in the dark in normal
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physiological saline solution (N-PSS) that contained (in
mM) 140 NaCl, 1 KCl, 1 CaCl
2
, 1 MgCl
2
, 10 glucose, and 5
HEPES (pH 7.4) at 37∘C. After being rinsed twice with N-
PSS, cells were kept in N-PSS for another 10min, and then
the circular discs with HAECs attached were placed on the
stage of a confocal microscope. While the images were being
acquired, 100𝜇M agonist baclofen was added to the assay
disc at the set time points. To determine the impact of the
antagonist, cells were preincubated for 10min with 1mM
of the GABAB receptor antagonists CGP46381 (Santa Cruz,
CA, USA) and CGP55845 (Tocris Bioscience, USA) before
100 𝜇M baclofen (Sigma, MO, USA) was added. Sequences
of images were acquired using the laser confocal microscope
(LSM 710, Zeiss, Germany) equipped with a 488 nm laser
at 5 s intervals. The fluorescence intensity over the HAECs
cell body was measured before and after agent application.
The fluorescence intensity before addition of agents was
considered the baseline fluorescence intensity.The changes of
fluorescence intensity after agent application were calculated
and analyzed by using ZEN 2009 Light Editin software (Zeiss,
Germany). PBS instead of GABAB agents were used as the
control.
2.6. eNOS Translocation. eNOS translocation was investi-
gated using immunofluorescence as previously described [33]
with minor modification. To test the effects of the GABAB
receptor agonist on eNOS translocation, cells were treated
with 100 𝜇Mbaclofen for 30min. To determine the impact of
the antagonist, cells were preincubated for 10min with 1mM
of theGABAB receptor antagonists CGP46381 andCGP55845
before 100 𝜇M baclofen was added.
2.7. Statistical Analysis. All data were analyzed using SPSS
v16.0 (SPSS Inc., Chicago, IL, USA). Data were acquired from
at least 3 independent repeats of the experiments and were
expressed as mean ± SD.
3. Results
Real-time PCR demonstrated the presence of GABAB1,
GABAB2, and 𝛽-actin mRNA in cultured HAECs and in
human retina, but not in the negative control. Results from
ethidium bromide-stained agarose gels electrophoresis of
the real-time PCR products demonstrated that the specific
bands appeared at the position of 228 bp (GABAB1), 220 bp
(GABAB2), and 302 bp (𝛽-actin), respectively (Figure 1).
Nucleotide sequence analysis confirmed that the sequence of
the PCR products is corresponding to the targeted sequence
of GABAB1 and GABAB2 mRNA with the primers.
3.1. GABA
𝐵1
and GABA
𝐵2
Protein Were Detected in Cultured
HAECs. Western blots analysis revealed that specific
protein bands appeared at approximately 108 kDa (GABAB1),
130 kDa (GABAB2), and 43 kDa (𝛽-actin) (Figure 2(a)).
Immunoreactivities to antibodies for GABAB1 and GABAB2
were observed in cultured HAECs. Immunofluorescence was
observed in the cell membrane and cytoplasm but not in
M
N.C HAEC P.C N.C HAEC P.CN.C HAEC P.C
GABAB2 GABAB1 𝛽-Actin
600bp
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Figure 1: Expression of GABAB1 and GABAB2 mRNA in HAECs.
Sample ethidium bromide gel of real-time PCR products of GABAB1
and GABAB2 receptors in HAECs and retina. M: DNA marker;
GABAB1: GABAB receptor subunit 1 (220 bp); GABAB2: GABAB
receptor subunit 2 (228 bp). N.C: negative control; HAECs: human
aortic endothelial cells; P.C: human retina (positive control).
the nucleus (Figure 2(b)). These data confirmed the expres-
sion of GABAB1 and GABAB2 receptor protein in HAECs.
3.2. GABA
𝐵
Receptors Regulate [Ca2+]i in Cultured HAECs.
The GABAB receptor agonist baclofen (100 𝜇M) induced
a rapid and transient rise of [Ca2+]i in HAECs. [Ca2+]i
reached its peak level in 20–40 s and then gradually declined
(Figure 3(a)). The increase of [Ca2+]i induced by 100 𝜇M
baclofen was partly (∼50%) abolished by preincubation with
1mM CGP46381 (Figure 3(b)) and was completely inhibited
by preincubation with 1mM CGP55845 (Figure 3(c)). PBS
did not cause increase in [Ca2+]i of the cultured HAECs.
3.3. GABA
𝐵
Receptors Modulate eNOS Translocation in
Cultured HAECs. In control HAECs, eNOS immunostain-
ing was predominantly located at the cell membrane and
cytoplasm (Figure 4(a)). One hundred 𝜇M baclofen incu-
bated HAECs (incubation for 30min) showed that eNOS
immunostaining was changed to intracellular sites close to
the nucleus (Figure 4(b)). Preincubation of CGP46381 and
CGP55845 for 10min inhibited 100𝜇M baclofen induced
translocation of eNOS in HAECs (Figures 4(c) and 4(d)).
4. Discussion
In the study we found that GABAB1 and GABAB2 mRNA and
protein were expressed in cultured HAECs; the two subunits
were colocated in the cell membrane and cytoplasm, but
neither was located in the nucleus. The GABAB receptor
agonist baclofen induced a transient increase of [Ca2+]i
and eNOS translocation and the effects were attenuated by
the GABAB receptor antagonists CGP46381 and CGP55845.
These findings suggest that GABAB receptors are expressed
in cultured HAECs and regulate the [Ca2+]i and eNOS
translocation.
Muscarinic receptors [20, 21], 𝛽-adrenoceptors [22, 23],
and 5-HT receptors [24–26] that are primarily located in
central neural system are also present within the peripheral
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Figure 2: Expression of GABAB1 and GABAB2 protein detected by western blots (a) and immunofluorescence (b). (a) Specific bands
developed at the approximate location of 108 kD (GABAB1), 130 kD (GABAB2), and 43 kD (𝛽-Actin) in lysates of HAECs and retina (P.C).
(b) Representative dual immunofluorescence staining of GABAB1 and GABAB2 in HAECs. Nuclei were stained by DAPI (blue) (scale bar =
50 𝜇m). HAECs: human aortic endothelial cells; P.C: human retina (positive control).
vascular endothelial cells and modulate the [Ca2+]i. Here we
add GABAB receptors to the list. Whether GABAB receptor
functions involving intracellular Ca2+ are similar to those
of other neural-transmitters requires further investigation.
Possibilities include proliferation [14], apoptosis [15], perme-
ability [16], and eNOS activation [17].
The [Ca2+]i changes in vascular endothelial cells have
been reported to be involved in eNOS activity, which mainly
include eNOS translocation and phosphorylation [17, 27].
eNOS translocation from the plasma membrane to sub-
cellular locations contributes to eNOS functions, such as
permeability [27], and thecell membrane-bound and Golgi-
bound eNOS are considered to have the ability to releasemore
basal NO than cytosolic eNOS [27]. We found that GABAB
receptors modify the eNOS translocation by moving eNOS
from the cell membrane and cytoplasm to the cytoplasm
closer to the nucleus. It is thus possible that GABAB receptors
in HAECs regulate NO production and modify vascular
permeability [27].
GABAB receptors have been reported to be involved in
regulating vasculature functions, but the mechanisms are
complex. In addition to the central neural system mecha-
nisms [38–40], GABAB receptors directly regulate the vas-
culature functions via a peripheral mechanism. The GABAB
receptor agonist, SKF-97541, induces vasodepression in the
feline pulmonary vascular bed and these responses are atten-
uated after the administration of a GABAB receptor antag-
onist, saclofen [41]. The GABAB receptor agonist baclofen
causes vasodilation in 50% of vessels in the rat retina; the
vasodilation can be blocked by the GABAB receptor antag-
onist 2-hydroxysaclofen [42]. Here we verified that GABAB
receptors are expressed and located in cultured HAECs and
regulate [Ca2+]i and eNOS translocation. These suggested
that vascular endothelial cells would be the potential targets
for GABAB receptors directly modulating vascular functions.
In summary, GABAB1 and GABAB2 mRNA and protein
were expressed in cultured HAECs and GABAB receptors
modified [Ca2+]i and eNOS translocation; this suggests a
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Figure 3: GABAB receptors regulate [Ca
2+]i in HAECs. (a) 100 𝜇M baclofen caused increase of [Ca2+]i in the cultured HAECs. (b)
Pretreatment with 1mMCGP46381 partly (∼50%) abolished the increase of [Ca2+]i induced by 100𝜇Mbaclofen. (c) Pretreatment with 1mM
CGP55845 completely inhibited the increase of [Ca2+]i induced by 100𝜇M baclofen. (A) Representative images acquired at 5 s, 38.94 s, and
148.96 s, respectively. (B) Fluorescent intensity in the images acquired before and after baclofen application. The red bar represents the time
when baclofen was added. FI represents the fluorescence intensity color scale with the direction of the arrow indicating higher intensity.
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Figure 4:GABAB receptors regulate eNOS translocation inHAECs. (a) In controlHAECs, eNOS immunostainingwas predominantly located
at the cell membrane and cytoplasm. (b) 100𝜇M baclofen incubated HAECs (incubation for 30min) showed that eNOS immunostaining
location was changed to intracellular sites close to the nucleus. (c) Preincubation of CGP46381 for 10min inhibited 100𝜇M baclofen induced
translocation of eNOS in HAECs. (d) Preincubation of CGP55845 for 10min inhibited 100 𝜇M baclofen induced translocation of eNOS in
HAECs. Images are at ×400 magnification. Scale bar = 20 𝜇m.
possible role of GABAB receptors in the mediation of HAECs
functions. Further investigation is required regarding which
specific HAEC functions (e.g., proliferation, apoptosis, and
permeability) GABAB receptors regulate.
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